Table 1 Demographic and clinical characteristics of the sample
From: Validity of subjective versus objective quality of life assessment in people with schizophrenia
Baseline variables (N = 80) | |||
|---|---|---|---|
Gender, Male (%) | 54 (68%) | ||
Smoking, Yes (%) | 61 (76%) | ||
Current drug use, Yes (%) | 23 (29%) | ||
Current alcohol use, Yes (%) | 23 (29%) | ||
Mean (SD) | Median | Range | |
Age (yr) | 39.8 (10.9) | 40.1 | 18.5 - 60.1 |
Duration of Illness (yr) | 13.16 (11.24) | 9.04 | 0 - 38 |
Number of previous hospitalisations | 4.78 (5.89) | 3.00 | 0 - 40 |
Patient-rated QoL (LQOLP average) | 3.95 (1.48) | 3.50 | 1 – 7 |
Assessor-rated QoL (QLS total score) | 41.61 (17.55) | 39.00 | 11 – 91 |
Insight (BIS) | 12.15 (3.45) | 12.00 | 2 – 16 |
Depression (CDSS) | 9.04 (6.21) | 8.00 | 0 – 22 |
Positive symptoms (PANSS) | 16.89 (6.14) | 16.00 | 7 – 32 |
Negative symptoms (PANSS) | 20.61 (5.49) | 20.50 | 9 – 39 |
General psychopathology (PANSS) | 40.33 (9.74) | 40.50 | 22 - 64 |
Total symptom score (PANSS) | 77.83 (17.44) | 76.50 | 45 – 128 |
Adherence Rating (Kemp) | 5.04 (1.44) | 5.00 | 1 - 7 |
Drug Attitude (DAI) | +11.08 (10.95) | +10.00 | −18 - +30 |
Simpson-Angus | 4.64 (4.23) | 4.00 | 0 – 22 |
Barnes Akathisia | 3.63 (3.18) | 3.50 | 0 – 11 |
AIMS | 1.60 (2.59) | 1.00 | 0 – 15 |
Non-neurological side effects (ANNSERS) | 19.37 (10.13) | 20.00 | 1 – 39 |
Body Mass Index (BMI) | 26.83 (6.33) | 26.10 | 16.5 – 50 |